Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |